Bacteremia Clinical Trials

14 recruiting

Bacteremia Trials at a Glance

33 actively recruiting trials for bacteremia are listed on ClinicalTrialsFinder across 6 cities in 26 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Montreal, Calgary, and Surrey. Lead sponsors running bacteremia studies include Assistance Publique - Hôpitaux de Paris, Rambam Health Care Campus, and Region Skane.

Browse bacteremia trials by phase

Treatments under study

About Bacteremia Clinical Trials

Looking for clinical trials for Bacteremia? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bacteremia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bacteremia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 33 trials

Recruiting
Phase 4

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)Staphylococcus Aureus BacteraemiaStaphylococcal Bacteraemia+1 more
Region Skane420 enrolled1 locationNCT06726395
Recruiting
Phase 4

Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)

SepsisInfectionsBacteremia
Murdoch Childrens Research Institute40 enrolled4 locationsNCT05770622
Recruiting

Febrile Infants Swedish Study

Serious Bacterial InfectionSepsisBacteremia+4 more
Region Skane2,000 enrolled11 locationsNCT07134751
Recruiting
Not Applicable

Linezolid Plus Standard of Care

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
University Hospital, Basel, Switzerland606 enrolled12 locationsNCT06958835
Recruiting

Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge

Bacteremia
Methodist Health System126 enrolled1 locationNCT07486362
Recruiting
Phase 4

Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia

Staphylococcus Aureus BacteremiaStaphylococcus Aureus EndocarditisStaphylococcus Aureus Septicemia+3 more
McGill University Health Centre/Research Institute of the McGill University Health Centre300 enrolled1 locationNCT06650501
Recruiting

Structural and Microbiological Characterization of Arterial Catheter Biofilm in ICU's Patients Using Optical Coherence Tomography

BacteremiaBiofilmsArterial Catheterization, Peripheral
Centre Hospitalier William Morey - Chalon sur Saône60 enrolled2 locationsNCT06838598
Recruiting
Not Applicable

Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

Gram-negative Bacteremia
Johns Hopkins University1,030 enrolled11 locationsNCT06080698
Recruiting

A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection

Bacteremia Caused by Gram-Negative BacteriaBacterial Pneumonia
TTY Biopharm480 enrolled1 locationNCT06966284
Recruiting
Phase 4

Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia

Staphylococcus Aureus BacteremiaStaphylococcus Aureus EndocarditisStaphylococcus Aureus Septicemia+2 more
Todd C. Lee MD MPH FIDSA300 enrolled14 locationsNCT06637332
Recruiting

Clinical Efectiveness of a Multiplex PCR-Based Rapid Diagnostic Method in Bloodstream Infections

Bloodstream InfectionsBacteremia and SepsisFungemia
Istanbul Medipol University Hospital300 enrolled1 locationNCT07408544
Recruiting
Phase 2

Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

Staphylococcus Aureus BacteremiaStaphylococcus Aureus EndocarditisStaphylococcus Aureus Septicemia+1 more
Todd C. Lee MD MPH FIDSA60 enrolled5 locationsNCT04886284
Recruiting
Not Applicable

A Platform Trial for Gram Negative Bloodstream Infections

Gram-negative Bacteremia
Sunnybrook Health Sciences Centre2,500 enrolled39 locationsNCT06537609
Recruiting

Treatment of Enterococcus Faecalis Bacterem

Enterococcus Faecalis Bacteremia
University Hospital, Strasbourg, France700 enrolled1 locationNCT07299539
Recruiting
Not Applicable

Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3

Staphylococcus AureusBacteremiaInfective Endocarditis
Assistance Publique - Hôpitaux de Paris700 enrolled1 locationNCT06457386
Recruiting
Phase 4

Staphylococcus Aureus Network Adaptive Platform Trial

Staphylococcus Aureus Bacteremia
University of Melbourne8,000 enrolled151 locationsNCT05137119
Recruiting
Not Applicable

Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis

SepsisSeptic ShockSepsis Mrsa+4 more
Children's Hospital of Philadelphia52,500 enrolled4 locationsNCT05975671
Recruiting
Not Applicable

Reducing Risk for Infective Endocarditis

BacteremiaInfective Endocarditis
Wake Forest University Health Sciences320 enrolled6 locationsNCT05721781
Recruiting

Prospective Validation of GRADY: A Machine Learning Model for Early Sepsis and Bacteremia Detection in ICU Patients

BacteremiaSepsis Bacterial
Sisli Hamidiye Etfal Training and Research Hospital55 enrolled1 locationNCT07126106
Recruiting
Phase 4

Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii

Carbapenem Resistant Bacterial InfectionAcinetobacter BacteremiaAcinetobacter Pneumonia
Rambam Health Care Campus734 enrolled3 locationsNCT05922124